
Salem Biomedical Research Private Limited
About Salem Biomedical Research Private Limited
Data last updated:
Salem Biomedical Research Private Limited was a private limited company based in Salem, Tamil Nadu, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the research and development sector. It was incorporated on 24 August 2005.
The company was registered with the Registrar of Companies (ROC), Coimbatore, under CIN U73100TZ2005PTC012073.
The company had an authorised share capital of ₹40 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors including George Paul (Whole-Time Director) and Nareshalal Kishindas Kinger (Whole-Time Director).
Its last annual general meeting (AGM) was held on 28 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office was at F 72 Brindavan Roadfairlands Salem, Tamil Nadu, India – 636002.
As per the financials filed for FY 2019, the company reported a revenue of ₹28,666, a decline of 99% compared to the previous year. For the same year it recorded a net loss of ₹4.59 Lakh and EBITDA of -₹4.58 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 19% over three years.
Company details
Contact details
Salem Biomedical Research Private Limited's registered office is in Salem, Tamil Nadu.
- Registered AddressF 72 Brindavan Roadfairlands Salem, Tamil Nadu, India – 636002
- IndustryResearch & Development, Research & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Salem Biomedical Research Private Limited
FY 2019 filings availableSalem Biomedical Research Private Limited reported revenue of ₹28,666 (down 99% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 19% over three years, including a 99% fall in the latest year. EBITDA fell 458% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4.58 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.59 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Salem Biomedical Research Private Limited, buy the company report.
Board of directors of Salem Biomedical Research Private Limited
Salem Biomedical Research has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| George Paul | Whole-Time Director | 24 Aug 2005 | 21 Years 2 Months | As last reported |
| Nareshalal Kishindas Kinger | Whole-Time Director | 24 Aug 2005 | 21 Years 2 Months | As last reported |
| Sanjiv Chandrasekharan Nair | Whole-Time Director | 24 Aug 2005 | 21 Years 2 Months | As last reported |
Legal cases
No court or tribunal cases involving Salem Biomedical Research Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Salem Biomedical Research Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Salem Biomedical Research Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Salem Biomedical Research Private Limited has 7 board changes on record since 2005: 3 appointments and 4 cessations. The latest: Pillai Krishnan Mohanaram ceased to be Whole-Time Director on 23 Mar 2018.
Frequently asked questions
Salem Biomedical Research has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Salem Biomedical Research was a private limited company based in Salem, Tamil Nadu, India. The company worked in the research and development industry. It was incorporated on 24 August 2005 and is registered under CIN U73100TZ2005PTC012073. The company has been struck off by the Registrar of Companies and is no longer operational.
Salem Biomedical Research had 3 directors:
- George Paul - Whole-Time Director
- Nareshalal Kishindas Kinger - Whole-Time Director
- Sanjiv Chandrasekharan Nair - Whole-Time Director
The CIN (Corporate Identification Number) of Salem Biomedical Research is U73100TZ2005PTC012073. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Salem Biomedical Research is at F 72 Brindavan Roadfairlands Salem, Tamil Nadu, India – 636002.
Salem Biomedical Research was incorporated on 24 August 2005. It is registered with the Registrar of Companies, Coimbatore.
The latest financial statements of Salem Biomedical Research on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 28 September 2019. Year-wise statements from 2015 are in the company report.
Salem Biomedical Research operated in the research and development industry. It worked in this industry before it was struck off.
Pillai Krishnan Mohanaram ceased to be Whole-Time Director on 23 Mar 2018. George Paul ceased to be Director on 04 Oct 2017. Nareshalal Kishindas Kinger ceased to be Director on 04 Oct 2017. Salem Biomedical Research has 7 board changes on record in total.
The compliance status of Salem Biomedical Research is compliant as of 27 August 2026.

